Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

We are the first Royal Society of Chemistry journal to be gold open access from launch – allowing a global, interdisciplinary network of nanoscale researchers free access to quality, field-advancing ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Setting, participants and outcome measures Electronic databases, MEDLINE and Embase, were searched for validation studies where an administrative case definition (using ICD codes) for diabetes in ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with ...

Semaglutide, the medication better known as Ozempic, reduces the symptoms of a condition that can lead to lower limb amputations in people with diabetes, according to a new study that reinforces ...

- Zimislecel (VX-880) pivotal trial on track to complete enrollment and dosing in H1 2025; Vertex expects to submit marketing applications to global regulators in 2026 - Vertex has completed ...

Early-life exposure to antibiotics can disrupt the growth of insulin-producing cells in the pancreas by altering the infant microbiome, increasing the risk of diabetes later on, according to new mouse ...

Constipation is a common complication in people living with diabetes. This is due to how diabetes can impact the nerves that control the digestive tract. Learn what you can do to relieve it.

People who might be considered thin or skinny can develop prediabetes, type 2, and gestational diabetes. Weight is one possible risk factor, including age, family medical history, and ethnicity.

Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs’ safety and effectiveness in this patient ...